PSMD1 and COVID-19: Park et al. showed a higher incidence of general post-vaccination symptoms and a greater need for antipyretics in the group of subjects with a confirmed immune response in the form of anti-S1 antibody synthesis to the first dose of vector vaccine against COVID-19 [35].